Procept BioRobotics [PRCT] vs Artivion [AORT] Detailed Stock Comparison

Procept BioRobotics

NASDAQ
Loading...

Artivion

NYSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Procept BioRobotics wins in 5 metrics, Artivion wins in 13 metrics, with 0 ties. Artivion appears stronger overall.

View Metrics Details

Vital Metrics Comparison

MetricProcept BioRoboticsArtivionBetter
P/E Ratio (TTM)-19.85-128.47Artivion
Price-to-Book Ratio5.144.75Artivion
Debt-to-Equity Ratio20.5762.81Procept BioRobotics
PEG Ratio0.660.80Procept BioRobotics
EV/EBITDA-20.5148.19Procept BioRobotics
Profit Margin (TTM)-30.60%-4.43%Artivion
Operating Margin (TTM)-28.02%9.72%Artivion
EBITDA Margin (TTM)N/A9.72%N/A
Return on Equity-26.40%-5.02%Artivion
Return on Assets (TTM)-12.93%1.70%Artivion
Free Cash Flow (TTM)$-103.62M$11.05MArtivion
Dividend Yield0.64%N/AN/A
1-Year Return-52.11%53.48%Artivion
Price-to-Sales Ratio (TTM)7.424.93Artivion
Enterprise Value$1.76B$2.19BArtivion
EV/Revenue Ratio6.415.42Artivion
Gross Profit Margin (TTM)65.35%64.72%Procept BioRobotics
Revenue per Share (TTM)$5$10Artivion
Earnings per Share (Diluted)$-1.50$-0.44Artivion
Beta (Stock Volatility)1.031.70Procept BioRobotics
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends

Procept BioRobotics vs Artivion Stock Performance Analysis

Loading Price Chart...

Procept BioRobotics
Artivion
Procept BioRobotics Stock Overview | Artivion Stock Overview

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Procept BioRobotics0.20%-6.00%-12.05%-40.19%-39.73%-58.15%
Artivion-1.26%0.40%-7.14%31.57%62.04%44.55%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Procept BioRobotics-52.11%-13.09%-13.00%-13.00%-13.00%-13.00%
Artivion53.48%250.13%110.15%296.68%555.57%472.36%

News Based Sentiment: Procept BioRobotics vs Artivion

Procept BioRobotics

News based Sentiment: MIXED

September presented a mixed bag for Procept BioRobotics, with strong Q2 earnings and positive analyst ratings countered by stock volatility, insider selling, and downward price target revisions. The conflicting signals create a complex investment picture, making it a significant month for the company's trajectory.

View Procept BioRobotics News Sentiment Analysis

Artivion

News based Sentiment: MIXED

October was a mixed month for Artivion, with a significant earnings beat and positive analyst revisions offset by notable insider selling and fluctuating stock performance. The combination of positive financial results and concerning insider activity creates a complex investment narrative, making it a moderately important month for investors.

View Artivion News Sentiment Analysis

Performance & Financial Health Analysis: Procept BioRobotics vs Artivion

MetricPRCTAORT
Market Information
Market Cap i$1.99B$1.94B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i902,800469,077
90 Day Avg. Volume i951,347440,382
Last Close$34.80$40.59
52 Week Range$34.01 - $103.81$21.97 - $45.07
% from 52W High-66.48%-9.94%
All-Time High$103.81 (Nov 11, 2024)$45.07 (Aug 22, 2025)
% from All-Time High-66.48%-9.94%
Growth Metrics
Quarterly Revenue Growth0.48%0.15%
Quarterly Earnings Growth0.48%0.15%
Financial Health
Profit Margin (TTM) i-0.31%-0.04%
Operating Margin (TTM) i-0.28%0.10%
Return on Equity (TTM) i-0.26%-0.05%
Debt to Equity (MRQ) i20.5762.81
Cash & Liquidity
Book Value per Share (MRQ)$6.94$8.91
Cash per Share (MRQ)$5.44$1.13
Operating Cash Flow (TTM) i$-83,214,000$19.65M
Levered Free Cash Flow (TTM) i$-59,140,124$-12,697,875
Dividends
Last 12-Month Dividend Yield i0.64%N/A
Last 12-Month Dividend i$0.38$0.00

Valuation & Enterprise Metrics Analysis: Procept BioRobotics vs Artivion

MetricPRCTAORT
Price Ratios
P/E Ratio (TTM) i-19.85-128.47
Forward P/E i-26.83176.31
PEG Ratio i0.660.80
Price to Sales (TTM) i7.424.93
Price to Book (MRQ) i5.144.75
Market Capitalization
Market Capitalization i$1.99B$1.94B
Enterprise Value i$1.76B$2.19B
Enterprise Value Metrics
Enterprise to Revenue i6.415.42
Enterprise to EBITDA i-20.5148.19
Risk & Other Metrics
Beta i1.031.70
Book Value per Share (MRQ) i$6.94$8.91

Financial Statements Comparison: Procept BioRobotics vs Artivion

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)PRCTAORT
Revenue/Sales i$69.16M$112.97M
Cost of Goods Sold i$25.00M$39.86M
Gross Profit i$44.16M$73.11M
Research & Development i$16.40M$7.06M
Operating Income (EBIT) i$-27.44M$8.38M
EBITDA i$-22.39M$18.95M
Pre-Tax Income i$-24.74M$3.48M
Income Tax iN/A$2.14M
Net Income (Profit) i$-24.74M$1.35M

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)PRCTAORT
Cash & Equivalents i$316.21M$37.69M
Total Current Assets i$465.79M$287.30M
Total Current Liabilities i$52.06M$51.94M
Long-Term Debt i$77.83M$356.98M
Total Shareholders Equity i$389.16M$294.25M
Retained Earnings i$-570.72M$-61.77M
Property, Plant & Equipment i$21.26M$77.04M

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)PRCTAORT
Operating Cash Flow i$-11.65M$-17.94M
Capital Expenditures i$-1.84MN/A
Free Cash Flow i$-18.82M$-20.59M
Debt Repayment iN/A$-66,000
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricPRCTAORT
Shares Short i8.15M1.08M
Short Ratio i8.522.52
Short % of Float i0.17%0.03%
Average Daily Volume (10 Day) i902,800469,077
Average Daily Volume (90 Day) i951,347440,382
Shares Outstanding i54.72M41.95M
Float Shares i53.56M41.61M
% Held by Insiders i0.05%0.05%
% Held by Institutions i0.98%0.90%

Dividend Analysis & Yield Comparison: Procept BioRobotics vs Artivion

MetricPRCTAORT
Last 12-Month Dividend i$0.38$0.00
Last 12-Month Dividend Yield i0.64%N/A
3-Year Avg Annual Dividend i$0.53$0.00
3-Year Avg Dividend Yield i0.12%N/A
3-Year Total Dividends i$1.59$0.00
Ex-Dividend DateMar 31, 2025N/A